Bajaj Healthcare Launches Drug for the Treatment of Mucormycosis Infection
Bajaj Healthcare has reportedly launched Posaconazole API which is used in the treatment of mucormycosis (black fungus) infection in COVID-19 patients. According to reports, a regulatory filing by Bajaj Healthcare states that the company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat, to manufacture and market Posaconazole API as approved medication…
